Neuromyelitis Optica Drug Market Key Drivers and Forecast 2025-2032
Neuromyelitis Optica Drug Market Trends And Drivers The Neuromyelitis Optica (NMO) drug market was valued at USD 1.6 Billion in 2022 and is projected to reach USD 3.8 Billion by 2030, growing at a CAGR of 11.5% from 2024 to 2030. The growth is driven by the increasing prevalence of NMO and the growing awareness […]
Continue Reading